ClinicalTrials HQ

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Recruiting · NCT07429266 · Registry updated 2026-10-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasmRecruitingPhase 32026-10-05NCT07429266

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Deciphera Pharmaceuticals, LLC15
Ono Pharmaceutical Co., Ltd.47

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Central Georgia Cancer CareMaconUnited States5
Florida Clinical Trials GroupPlantationUnited States9
Florida Clinical Trials GroupTamaracUnited States5
Gabrail Cancer Center ResearchCantonUnited States26
Genesis Care WindsorWindsorUnited Kingdom1
Institute of Science Tokyo HospitalTokyoJapan1
Japanese Red Cross Nagasaki Genbaku HospitalNagasakiJapan3
MICS Centrum Medyczne TorunTorunPoland20
Montefiore Medical CenterThe BronxUnited States79
Osaka Metropolitan University HospitalOsakaJapan30
Perth Blood InstituteWest PerthAustralia3
Regis Clinical Research LLC.MiamiUnited States1
Royal Devon University Healthcare NHS Foundation TrustExeterUnited Kingdom3
The Cancer and Hematology CentersGrand RapidsUnited States2
The Center for Cancer & Blood DisordersBethesdaUnited States1
The New Castle upon Tyne HospitalNewcastle upon TyneUnited Kingdom1
Tokyo Women's Medical University HospitalTokyoJapan6